Literature DB >> 10968918

Experimental thrombosis and antiphospholipid antibodies: new insights.

S S Pierangeli1, A E Gharavi, E N Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968918     DOI: 10.1006/jaut.2000.0420

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


× No keyword cloud information.
  9 in total

1.  Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.

Authors:  C Hamid; K Norgate; D P D'Cruz; M A Khamashta; M Arno; J D Pearson; G Frampton; J J Murphy
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 2.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

3.  Relationship and significance between anti-beta2-glycoprotein I antibodies and platelet activation state in patients with ulcerative colitis.

Authors:  Yan-Hang Gao; Pu-Jun Gao; Chun-Guang Wang; Xiao-Cong Wang; Yun-Feng Piao
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.

Authors:  Gabriela Cesarman-Maus; Nina P Ríos-Luna; Arunkumar B Deora; Bihui Huang; Rosario Villa; Maria del Carmen Cravioto; Donato Alarcón-Segovia; Jorge Sánchez-Guerrero; Katherine A Hajjar
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

Review 5.  Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.

Authors:  O Shovman; B Gilburd; O Barzilai; P Langevitz; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

Review 6.  Antiphospholipid syndrome: an overview.

Authors:  John G Hanly
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

Review 7.  Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.

Authors:  Chieko Mineo
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

8.  A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.

Authors:  Gerd Gladigau; Philipp Haselmayer; Inge Scharrer; Markus Munder; Nadine Prinz; Karl Lackner; Hansjörg Schild; Pamela Stein; Markus P Radsak
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

9.  A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli.

Authors:  Yiannis Ioannou; Ian Giles; Anastasia Lambrianides; Chris Richardson; Laurence H Pearl; David S Latchman; David A Isenberg; Anisur Rahman
Journal:  BMC Biotechnol       Date:  2006-02-10       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.